🔎 Trials Near Me

Hjem › KOLS › Missouri

Kliniske studier for KOLS i Missouri

7 studier for KOLS søker deltakere på steder i Missouri.

Byer i Missouri

Offisiell studietekst (engelsk)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • University of Missouri Health Care - Children's Hospital- Site Number : 8400150, Columbia
  • Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
  • Washington University- Site Number : 8400144, St Louis
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD

  • Midwest Chest Consultants, P.C., Saint Charles
RekruttererFase 4
Alder 60 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07816835

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Chesterfield
  • Research Site, Hannibal
  • Research Site, St Louis
  • og 1 flere
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Hannibal
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, St Louis
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Washington University School of Medicine, St Louis
  • Barnes-Jewish Hospital Investigational Drug Service, St Louis
  • Barnes-Jewish Hospital, St Louis
  • og 2 flere
RekruttererFase 2/3
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.